Obalon Therapeutics, Inc. (OBLN) News
Filter OBLN News Items
OBLN News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
OBLN News Highlights
- 500 - Internal server error
- Over the past 21 days, the trend for OBLN's stories per day has been choppy and unclear. It has oscillated between 3 and 6.
Latest OBLN News From Around the Web
Below are the latest news stories about Obalon Therapeutics Inc that investors may wish to consider to help them evaluate OBLN as an investment opportunity.
Hedge Funds Are Betting On Obalon Therapeutics, Inc. (OBLN)No summary available. |
Is Obalon Therapeutics, Inc. (OBLN) Going to Burn These Hedge Funds?No summary available. |
DGAP-News: ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending MergerDGAP-News: ReShape Lifesciences Inc. / Key word(s): Merger ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger 08.06.2021 / 13:30 The issuer is solely responsible for the content of this announcement. ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending |
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending MergerSAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 8, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc. |
ReShape Lifesciences Inc., US67424L2097Reminder: Obalon Therapeutics, Inc. Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc |
ReShape Lifesciences Inc.: Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape LifesciencesSAN DIEGO, CA / ACCESSWIRE / May 24, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled i |
DGAP-News: Reminder: Obalon Therapeutics, Inc. Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences IncDGAP-News: ReShape Lifesciences Inc. / Key word(s): Miscellaneous Reminder: Obalon Therapeutics, Inc. Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc 24.05.2021 / 13:35 The issuer is solely responsible for the content of this announcement. Reminder: Obalon Therapeutics |
Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape LifesciencesObalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, is taking this opportunity to remind its stockholders to vote on all the proposals related to the proposed merger with ReShape Lifesciences Inc. in advance of the upcoming reconvened special meeting of Obalon stockholders n |
ReShape Lifesciences Inc.: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape LifesciencesSAN DIEGO, CA / ACCESSWIRE / May 21, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled i |
Obalon Therapeutics Stockholders Special Meeting Adjourned to May 25, 2021Urging all Shareholders to Vote For Proposals Related to Merger with ReShape LifeSciences Inc.Meeting to be held via Webcast at 8:30 a. |